Xiao C - Search Results

1

Multiple primary lung cancer: Updates of clinical management and genomic features.

Tian H, Bai G, Yang Z, Chen P, Xu J, Liu T, Fan T, Wang B, Xiao C, Li C, Gao S, He J. Tian H, et al. Among authors: xiao c. Front Oncol. 2023 Feb 22;13:1034752. doi: 10.3389/fonc.2023.1034752. eCollection 2023. Front Oncol. 2023. PMID: 36910635 Free PMC article. Review.

2

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.

Zheng Y, Tian H, Zhou Z, Xiao C, Liu H, Liu Y, Wang L, Fan T, Zheng B, Tan F, Xue Q, Gao G, Li C, He J. Zheng Y, et al. Among authors: xiao c. Front Cell Dev Biol. 2021 Mar 19;9:651406. doi: 10.3389/fcell.2021.651406. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33816503 Free PMC article.

3

H3K36 trimethylation-mediated biological functions in cancer.

Xiao C, Fan T, Tian H, Zheng Y, Zhou Z, Li S, Li C, He J. Xiao C, et al. Clin Epigenetics. 2021 Oct 29;13(1):199. doi: 10.1186/s13148-021-01187-2. Clin Epigenetics. 2021. PMID: 34715919 Free PMC article. Review.

4

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.

Yang Z, Tian H, Bie F, Xu J, Zhou Z, Yang J, Li R, Peng Y, Bai G, Tian Y, Chen Y, Liu L, Fan T, Xiao C, Zheng Y, Zheng B, Wang J, Li C, Gao S, He J. Yang Z, et al. Among authors: xiao c. Front Immunol. 2021 Dec 21;12:788985. doi: 10.3389/fimmu.2021.788985. eCollection 2021. Front Immunol. 2021. PMID: 34992605 Free PMC article.

5

PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.

Yang Z, Tian H, Li L, Li C, Xu J, Bie F, Chen Y, Tian Y, Bai G, Peng Y, Yang J, Fan T, Xiao C, Liu W, Liu L, Li R, Sun S, Zheng B, Tan F, Ying J, Li C, Gao S, He J. Yang Z, et al. Among authors: xiao c. Int J Cancer. 2022 Sep 1;151(5):717-729. doi: 10.1002/ijc.34137. Epub 2022 Jun 8. Int J Cancer. 2022. PMID: 35612583

6

Establishment and Validation of an Interferon-Stimulated Genes (ISGs) Prognostic Signature in Pan-cancer Patients: A Multicenter, Real-world Study.

Zhou Z, Zheng Y, Mo S, Li S, Zheng X, Wei R, Fan T, Chen T, Xiao C, Li C, He J. Zhou Z, et al. Among authors: xiao c. Int J Biol Sci. 2022 May 21;18(9):3762-3776. doi: 10.7150/ijbs.71385. eCollection 2022. Int J Biol Sci. 2022. PMID: 35813478 Free PMC article.

7

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition.

Fan T, Li S, Xiao C, Tian H, Zheng Y, Liu Y, Li C, He J. Fan T, et al. Among authors: xiao c. Int J Biol Sci. 2022 Jun 27;18(11):4275-4288. doi: 10.7150/ijbs.73275. eCollection 2022. Int J Biol Sci. 2022. PMID: 35864953 Free PMC article.

8

The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.

Zheng Y, Zhou Z, Wei R, Xiao C, Zhang H, Fan T, Zheng B, Li C, He J. Zheng Y, et al. Among authors: xiao c. J Transl Med. 2022 Jul 30;20(1):343. doi: 10.1186/s12967-022-03552-y. J Transl Med. 2022. PMID: 35907982 Free PMC article.

9

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy.

Xiao C, Tian H, Zheng Y, Yang Z, Li S, Fan T, Xu J, Bai G, Liu J, Deng Z, Li C, He J. Xiao C, et al. Front Cell Dev Biol. 2022 Sep 19;10:1013885. doi: 10.3389/fcell.2022.1013885. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36200045 Free PMC article. Review.

10

BATF reprograms the tumor immune status.

Fan T, Xiao C, Muhammad S, Li C, He J. Fan T, et al. Among authors: xiao c. Med. 2023 Jan 13;4(1):10-12. doi: 10.1016/j.medj.2022.12.004. Med. 2023. PMID: 36640752 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,669 results

Search Page

Filters